Stock & Company Details
Candel Therapeutics Inc $CADL
Price:
46,691,331
73M
$776M
52 Week High:
$66.15
10 Day Average Volume:
42,760,466
-6.24
50 Day Moving Average:
$156.49
52 Week Low:
$43.74
30 Day Average Volume:
49,506,373
$4.94
2021-02-05
0.95
30 Day Change:
13%
3 Month Change:
-0.32%
Health Technology
CADL technical indicators
Latest Candel Therapeutics Inc (CADL) indicator readings as of 2026-08-10.
CADL's 14-day RSI is 59.6, in neutral territory. At $10.50 it is trading 57.1% above its 200-day moving average of $6.68, and above its 50-day average of $9.46. Price sits near the upper Bollinger Band ($9.26 to $10.75). ADX reads 20.2, sitting between trending and range-bound.
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
Finance Bot
Ask your questions
Start by typing a question below.
